Can you check for drug interactions between rosuvastatin, diltiazem, and losartan?

Drug Interaction Assessment: Rosuvastatin, Diltiazem, and Losartan

The combination of rosuvastatin, diltiazem, and losartan can be used together, but requires dose adjustment of rosuvastatin due to a clinically significant interaction with diltiazem. There is no significant interaction between rosuvastatin and losartan.

Key Interaction: Rosuvastatin and Diltiazem

Diltiazem is a moderate CYP3A4 inhibitor that increases rosuvastatin exposure, though the interaction is less severe than with other statins. According to the 2016 American Heart Association guidelines, combination therapy with rosuvastatin and diltiazem results in a minor increase in statin exposure and is considered reasonable 1.

Critical Management Points:

• A non-CYP3A4-metabolized statin is preferred when combining with diltiazem 1
• Rosuvastatin is actually one of the preferred statins with diltiazem because it undergoes minimal CYP3A4 metabolism 1
• Unlike simvastatin or lovastatin (which show moderate increases in exposure with diltiazem), rosuvastatin shows only minor increases 1

Specific Dosing Guidance:

The FDA label for rosuvastatin does not list diltiazem as requiring dose adjustment 2. This is because rosuvastatin is primarily metabolized by CYP2C9 (not CYP3A4) and transporters (OATP1B1, BCRP), making it less susceptible to diltiazem's CYP3A4 inhibition 2.

Rosuvastatin and Losartan: No Interaction

There is no clinically significant drug interaction between rosuvastatin and losartan. Recent studies have demonstrated:

• Pharmacokinetic equivalence when these drugs are co-administered 3, 4
• A fixed-dose combination product containing both drugs (along with amlodipine and ezetimibe) showed bioequivalence to individual components 4
• The combination may even have synergistic beneficial effects on vascular remodeling 5

Monitoring Recommendations

Monitor for muscle-related symptoms (myalgia, weakness, dark urine) when using rosuvastatin with diltiazem, though the risk is lower than with CYP3A4-metabolized statins 1. Specifically watch for:

• Unexplained muscle pain or weakness
• Elevated creatine kinase (CK) levels
• Signs of rhabdomyolysis (rare but serious)

Common Pitfalls to Avoid:

1. Do not confuse rosuvastatin with simvastatin or lovastatin - these require strict dose limitations with diltiazem (≤10 mg and ≤20 mg daily, respectively) 1
2. Rosuvastatin does not require the same dose restrictions as CYP3A4-metabolized statins when combined with diltiazem
3. Asian patients may require additional caution with statin-calcium channel blocker combinations 1

Clinical Bottom Line

This three-drug combination is safe and commonly used in clinical practice for patients with both hypertension and dyslipidemia 3. The rosuvastatin-diltiazem interaction is manageable and does not require dose reduction in most cases, unlike combinations with simvastatin or lovastatin. Standard rosuvastatin dosing (5-40 mg daily) can be used, with routine monitoring for statin-related adverse effects.